ArticleJournal of managed care & specialty pharmacy2021

Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population.

Rashid Kazerooni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.